Zdrowie i gospodarka · 28/03/2001

Beverages: Bottled Water; Companion Document to Direct Final Rule

The Food and Drug Administration (FDA) is proposing to amend its bottled water quality standard by establishing allowable levels in its regulations for three residual disinfectants (chloramine, chlorine, and chlorine dioxide) and three types of disinfection byproducts (DBP's) (bromate, chlorite, and haloacetic acids (HAA5)). FDA also is proposing to revise the existing allowable level for the DBP total trihalomethanes (TTHM). Finally, FDA is also proposing to revise, for the three residual disinfectants and four types of DBP's only, the monitoring requirement for source water found in the current good manufacturing practice (CGMP) regulations for bottled water. As a consequence of FDA's amending the quality standard for these residual disinfectants and DBP's, bottled water manufacturers would be required to monitor their finished bottled water products for these disinfectants and DBP's at least once each year under the CGMP regulations for bottled water. Bottled water manufacturers also would be required to monitor for these contaminants at least once each year in their source water, unless the bottlers meet the criteria for the source water monitoring exemption under the proposed